Lenalidomide proved effective in multisystem Langerhans cell histiocytosis

Acta Oncologica

Volumn 51, Issue 3, 2012, Pages 412-415

  Szturz, Petr ^a   Adam, Zdeněk ^a   Šehák, Zdeněk ^b   Koukalová, Renata ^b   Šlaisová, Radka ^a   Stehlková, Olga ^a   Chovancová, Jana ^c   Klabusay, Martin ^a   Krejči, Marta ^a   Pour, Luděk ^a   Hájek, Roman ^a   Mayer, Jiří ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; LENALIDOMIDE; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; BACKACHE; CASE REPORT; DRUG EFFICACY; FEVER; HISTIOCYTOSIS X; HUMAN; LABORATORY TEST; LETTER; LYMPHADENOPATHY; LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NIGHT SWEAT; PRIORITY JOURNAL; RELAPSE; STEM CELL MOBILIZATION; THERAPY EFFECT; THROMBOSIS;

ADULT; ANTINEOPLASTIC AGENTS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; THALIDOMIDE; TREATMENT OUTCOME;

EID: 84859744972     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.631581     Document Type: Letter

References (10)

1. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1-11.
2. Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn R, Windebank KP. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch. Dis. Child 2009;94:376-80.
3. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 1997;28:9-14.
4. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: Diagnosis, natural history, management, and outcome. Cancer 1999;85:2278-90.
5. Gotz G, Fichter J. Langerhans'- cell histiocytosis in 58 adults. Eur J Med. Res. 2004;9:510-4.
6. Satter EK, High WA. Langerhans cell histiocytosis: A review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 2008;25:291-5.
7. McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer 2007;48:44-9.
8. Misery L, Larbre B, Lyonnet S, Faure M, Thivolet J. Remission of Langerhans cell histiocytosis with thalidomide treatment. Clin Exp Dermatol 1993;18:487.
9. Palumbo A, Rajkumar SV. Multiple myeloma: Chemotherapy or transplantation in the era of new drugs. Eur J Haematol 2010;84:379-90.
10. Vallet S, Palumbo A, Raje N, Boccadoro M, Anderson KC. Thalidomide and lenalidomide: Mechanism-based potential drug combinations. Leuk Lymphoma 2008;49:1238-45.